|This Slide: #84 of 100|
Slide #84. Cumberland Pharmaceuticals — Vaprisol from Astellas Pharma US, Inc.
Cumberland Pharmaceuticals (NASDAQ:CPIX)
Vaprisol from Astellas Pharma US, Inc.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol from Astellas Pharma US, Inc.
Cumberland Pharmaceuticals is a pharmaceutical company focused on the acquisition, development and commercialization of prescription products. Co.'s portfolio of U.S. Food and Drug Administration approved brands includes: Acetadote® (acetylcysteine) Injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) Injection, for the treatment of pain and fever; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; as well as Vaprisol® (conivaptan) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
Open the CPIX Page at The Online Investor »
Strong Buy (4.00 out of 4)
(ranked higher than approx. 95% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite